• June 18, 2021

Why US Is Temporarily Halting Use Of Johnson & Johnson’s COVID-19 Vaccine


By Lucky Uwakina (AGENDAWATCHDOG) – US. Federal health agencies will temporarily stop using Johnson & Johnson’s one-dose vaccine after six women developed blood clots, including one who died, according to officials and a new report Tuesday. 

The Food and Drug Adminstration announced the pause, saying there’ve been a half-dozen reports of a “rare & severe type of blood clot” in patients who received the vaccine. 

The clots were observed along with reduced platelet counts, making the usual treatment for blood clots — the blood thinner heparin — potentially “dangerous.”

“Right now, these adverse events appear to be extremely rare,” the agency teweeted in a joint statement with the Centers for Disease Control and Prevention. 

Those affected were six women, between the ages of 18 and 48, who developed the clots within about two weeks of vaccination, the New York Times reported. One died and a second in Nebraska was hospitalized in critical condition.

About 9 million more doses have shipped to states, according to the Centers for Disease Control and Prevention.

People who received the J&J vaccine who are experiencing severe headache, abdominal pain, leg pain or shortness of breath within three weeks after receiving the jab are advised to contact their health care provider.

The feds hope the pause will serve as a strong signal to states to do the same.


Agenda Watchdog

Read Previous

96 $2.8bn AKK Project Pipes Delivered By NNPC To Itakpe By Rail

Read Next

FG Unveils First Solar-Powered Charging Station